Griffin Durias is a Geneva, Illinois based male Optometrist who is specialized in Optometry. Active license number of Griffin Durias is 046011345 for Optometry in Illinois. Griffin Durias examine, diagnose, treat, and manage diseases, injuries, and disorders of the visual system, the eye, and associated structures as well as identify related systemic conditions affecting the eye. He completed pre-professional undergraduate education in a college or university and four years of professional education at a college of optometry, leading to the doctor of optometry (O.D.) degree. He is a eye health care professional who is state-licensed to diagnose and treat diseases and disorders of the eye and visual system.
Complete Profile:
Griffin Durias speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1700431087
NPI Enumeration Date:
05 Aug, 2019
NPI Last Update On:
14 Jul, 2023
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Griffin Durias are as mentioned below.
License Number
Specialization
State
Status
046011345
Optometry
Illinois
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2401 Kaneville Rd Ste 8, Geneva, Illinois
Zip:
60134-2577
Phone Number:
630-326-4417
Fax Number:
630-326-8764
Patients can reach Griffin Durias at 2401 Kaneville Rd Ste 8, Geneva, Illinois or can call to book an appointment on 630-326-4417. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.